development
-
KAIST President's Advisory Council starts to operate
KAIST President’s Advisory Council starts to operate
Composed of distinguished experts (six from abroad and seven from home) in the fields of industry, academy, and research
To suppose development plan, provide political advices, and help fund-raising
Consultation by distinguished experts from home and abroad starts to make KAIST (President Nam-Pyo Suh) one of world’s top technology and science universities.
KAIST held the first meeting of KAIST President’s Advisory Council (PAC), which has been composed for consultation over KAIST development plan (draft), at KAIST conference room, Wednesday, November 8, 2006.
At the meeting, general introduction of KAIST and presentation of business plan by each college were made, and KAIST Education Innovation Center’s undergraduate education innovation plan (draft) and research plan by each of five KAIST institutes were explained. At the meeting, the PAC members discussed items to be carried out for the development plan (draft) and advised substantial measures to achieve the goals. After the meeting, the PAC members visited two laboratories to observe research sites.
KAIST PAC is composed of celebrities possessing rich global management experiences at the top of the fields of industry, academy, and research from home and abroad and will perform various substantial roles such as suggesting development plans, providing political advices, and assisting fund-raising to advance KAIST into one of the world’s top 10 universities.
The overseas members of KAIST PAC are Neil Pappalardo, Chairman of MEDITECH, Hock Tan, Chairman of Technology Inc., Hiroyuki Yoshikawa, President of Japanese Institute of Advanced Industrial Science and Technology and former president of Tokyo University, John Holzrichter, President of Fannie and John Hertz Foundation, Jongmoon Lee, Chairman of AmBex Inc., and Byungjoon Park, CEO of Bureau Veritas CPS.
And, the domestic members of KAIST PAC are Kyesik Min, Vice-chairman of Hyundai Heavy Industries, Heekuk Lee, President of LG Electronics, Youngchul Hong, Chairman of KISWIRE, Heebum Lee, Chairman of Korean International Trade Association, Yoonwoo Lee, Vice-chairman of Samsung Electronics, Dongjin Kim, Vice-chairman of Hyundai Motors, Youngsik Myung, President of GS CALTEX.
2006.11.14 View 15917 -
CJIS donates development fund of two hundreds million won to KAIST
CJIS donates development fund of two hundreds million won to KAIST
CJ Investment & Securities Co., Ltd. (CJIS/ CEO Hong-Chang Kim) donated a development fund of two hundreds million won to KAIST (President Nam-Pyo Suh) on Monday, August 30 to contribute to the development of KAIST and its fostering of science genius.
At the donation ceremony held at the main conference room in KAIST main administration building, CJIS CEO Hong-Chang Kim said, “I am very pleased to contribute to the development of KAIST, which is developing into a world-class research university.” In response to this, KAIST president Nam-Pyo Suh said, “I am very grateful for CJIS’s support. I will do my best to make KAIST one of the world-class research universities to be the hub of the world as well as Korea in the field of the cutting-edge science and technology.”
2006.09.06 View 17361
-
Professor Chan Beum Park, requested for joint international research by a German biotechnology enterprise.
- Bitop AG (Germany) requested a joint development of medicines for Alzheimer’s disease
- The meaning of the financial support by European enterprise to the research result of domestic university.
Professor Chan Beum Park (Department of Materials Science and Engineering in KAIST/ President Nam Pyo Suh) has been entrusted with a joint international research for the development of medicines for Alzheimer’s disease from Bitop AG, German biotechnology enterprise.
KAIST recently agreed with Bitop AG to cooperate for a research program pursuing the development of inhibitors that inhibit the formation of plaque relevant to amyloid diseases like Alzheimer’s disease. Based on this agreement, KAIST will be provided with a financial support of sixty thousands Euro (about 74 million won) from Bitop AG.
Professor Park will perform the screening of inhibitors, which are the core of the research, and KAIST will share patent rights from the research with Bitop AG.
It is known that various degenerative nerve diseases like Alzheimer’s disease, Parkinson’s disease, mad cow disease, and so on arise mainly from the accumulation of pathological protein plaque termed amyloid, and environmental stress accelerates the diseases.
So far, no effective remedy has been developed for amyloid diseases.
Recently, the use of chemicals inhibiting the formation of amyloid has been raised as a potential remedy.
Natural small stress molecules extracted from microbes growing in extreme environments like volcanic region on the bottom of the deep sea, etc. are gaining attention as an amyloid inhibitor.
Professor Park found out for the first time in the world that Anti-stress materials are effective in inhibiting the formation of amyloid plaque and published that fact in several renowned European scientific journals.
After that, Professor Park was requested by Bitop AG for a joint research and has studied for the development of medicines for Alzheimer’s disease using various kinds of Anti-stress materials.
Professor Park said, “I’d like to grant a highly valuable meaning to this entrustment since it implies that European enterprises perceive the value of the research result by domestic universities and hope to promote research and development by providing practical financial support, etc. I wish this time’s entrustment will be a momentum to advance Korea’s research level one step higher through active joint researches with enterprises or institutes in U.S. and Europe as well as Bitop AG.”
Bitop AG is a German enterprise that produces various Anti-stress materials coming from extreme-loving microbes.
Currently, Anti-stress materials are being sold mainly as protein and cell protectants, cosmetic additives, health supplement, etc.
Anti-stress materials extracted from microbes well growing in extreme environment of one hundred centigrade or more are expected to perform a role of inhibitors that inhibit the formation of amyloid plaque, the main factor of stress-related degenerative nerve diseases like Alzheimer’s disease, etc. Such Anti-stress materials are gaining attention as a future medicine for Alzheimer’s disease, etc.
2006.09.05 View 18543